Selected article for: "antiviral activity and vitro activity potent"
Author: McCreary, Erin K; Pogue, Jason M
Title: Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
  • Document date: 2020_3_23
    • ID: j0i9ozsz_26
    Snippet: Nitazoxanide has demonstrated potent in vitro activity against SARS CoV-2, with an EC 50 at 48 hours of 2.12 µM in Vero E6 cells [3] . This potent activity is consistent with EC 50 values for nitazoxanide and its active metabolite, tizoxanide, against MERS-CoV in LLC-MK2 cells in which EC 50 values of 0.92 and 0.83 µM, respectively, have been demonstrated [39] . Nitazoxanide displays broad-spectrum in vitro antiviral activity against influenza,.....
    Document: Nitazoxanide has demonstrated potent in vitro activity against SARS CoV-2, with an EC 50 at 48 hours of 2.12 µM in Vero E6 cells [3] . This potent activity is consistent with EC 50 values for nitazoxanide and its active metabolite, tizoxanide, against MERS-CoV in LLC-MK2 cells in which EC 50 values of 0.92 and 0.83 µM, respectively, have been demonstrated [39] . Nitazoxanide displays broad-spectrum in vitro antiviral activity against influenza, respiratory syncytial virus, parainfluenza, rotavirus, and norovirus among others in addition to coronaviruses [39] . This broad-spectrum antiviral activity is believed to be due to the fact that the mechanism of action is based on interference with host-regulated pathways involved in viral replication rather than virus-specific pathways [39] .

    Search related documents:
    Co phrase search for related documents
    • action mechanism and broad spectrum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and broad spectrum antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • action mechanism and host regulate: 1, 2, 3
    • action mechanism and influenza antiviral activity: 1, 2, 3, 4, 5
    • action mechanism and potent activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and respiratory syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • action mechanism and syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • action mechanism and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and vitro activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active metabolite and antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • active metabolite and broad spectrum: 1, 2, 3, 4, 5
    • active metabolite and broad spectrum antiviral activity: 1
    • active metabolite and potent activity: 1, 2, 3, 4
    • active metabolite and respiratory syncytial virus: 1
    • active metabolite and syncytial virus: 1
    • active metabolite and tizoxanide active metabolite: 1, 2, 3, 4
    • active metabolite and tizoxanide active metabolite nitazoxanide: 1, 2
    • active metabolite and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • active metabolite and vitro activity: 1, 2, 3, 4, 5, 6, 7, 8, 9